-
Mashup Score: 4Moving the Needle in ER-Positive / HER2-Negative MBC - 2 day(s) ago
Join us for this social media event on treating estrogen receptor (ER)-positive / HER2-negative metastatic breast cancer designed to encourage the exchange o…
Source: www.youtube.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 2Home - 2 day(s) ago
Activity Overview
Source: events.medscapelive.orgCategories: General Medicine News, Oncologists1Tweet-
🎗️ Address unmet needs in HR-positive/HER2-negative breast cancer care. 🔬 Explore biomarkers, tailor treatments, and manage AEs with confidence. 💡 Utilize the latest evidence to select optimal therapies for your patients. Learn more: https://t.co/ajKALoIVca #BreastCancerCare https://t.co/IsSkwkkeWo
-
-
Mashup Score: 1The Evolving Role of Menin Inhibitors in Acute Leukemias - 3 day(s) ago
KMT2A-rearranged (KMT2Ar) and NPM1-mutated (mNPM1) subtypes of acuteleukemias have emerged as an area of interest due to their distinct biologicalbehaviors a…
Source: www.youtube.comCategories: General Medicine News, Oncologists1Tweet-
Menin inhibitors, alone or in combination, have shown a lot of promise in treatment for patients w/ KMT2Ar and mNPM1 subtypes of acute leukemias. 𝐋𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞 𝐋𝐈𝐕𝐄 with @EuniceWangMD and @LeukDocJZ on Dec 17 ➡️ https://t.co/hnleS9GNBw https://t.co/gCn4Y2Pzjc
-
-
Mashup Score: 1Patient-Centered Care With Asparaginase Therapies at #ASH24 - 6 day(s) ago
Join us at #ASH24 for “Patient-Centered Care With Asparaginase Therapies,” exploring innovations in oncology treatment and patient-focused approaches.
Source: na.eventscloud.comCategories: General Medicine News, Oncologists1Tweet-
🔬 Gain expertise in therapeutic monitoring for ALL/LBL patients on asparaginase therapies. 📈 Learn to select optimal treatments and manage toxicities effectively. Enhance your skills in patient communication about ALL/LBL management. https://t.co/KVEktvlmlV #ASH23 https://t.co/Fob4AlVrID
-
-
Mashup Score: 0Home - 6 day(s) ago
Activity Overview
Source: na.eventscloud.comCategories: General Medicine News, Oncologists1Tweet-
🔬 Discover the key differences between current & emerging bispecific antibodies for R/R FL with @LornaWarwick, @KrishPatelMD, and @JoshuaBrodyMD. Enhance your skills in managing therapy and AEs with bispecific antibodies. 👉 https://t.co/ghJZRXmBTJ #ASH24 https://t.co/y1WBOTwjl6
-
-
Mashup Score: 1Patient-Centered Care With Asparaginase Therapies at #ASH24 - 6 day(s) ago
Join us at #ASH24 for “Patient-Centered Care With Asparaginase Therapies,” exploring innovations in oncology treatment and patient-focused approaches.
Source: na.eventscloud.comCategories: General Medicine News, Oncologists1Tweet-
🔬 Gain expertise in therapeutic monitoring for ALL/LBL patients on asparaginase therapies. 📈 Learn to select optimal treatments and manage toxicities effectively. Enhance your skills in patient communication about ALL/LBL management. https://t.co/KVEktvlmlV #ASH23 https://t.co/Fob4AlVrID
-
-
Mashup Score: 0Gene Therapies for Hemophilia A and Hemophilia B at #ASH24 - 6 day(s) ago
Explore groundbreaking gene therapies for Hemophilia A and B at #ASH24. Join leading experts for insights into the latest advancements, treatment strategies, and research updates in gene therapy. Stay at the forefront of hemophilia care with cutting-edge discussions and developments.
Source: events.medscapelive.orgCategories: General Medicine News, Oncologists1Tweet-
🚨 TOMORROW! Uncover the latest on gene therapies 🧬 for hemophilia at #ASH24! 🩺 Get insights into clinical differences, refine patient monitoring, and confidently guide treatment decisions. 🔍 Discover more: https://t.co/aVbLY5aT4K https://t.co/RmIs89IXy9
-
-
Mashup Score: 1Home - 7 day(s) ago
Activity Overview
Source: na.eventscloud.comCategories: General Medicine News, Oncologists1Tweet-
🔬 Discover the latest on complement-based therapies for PNH! Enhance your skills in identifying patients and creating tailored care plans. 🗣️ Boost your confidence in using effective communication for shared decision-making. Click here: https://t.co/VwFESDOQgO #ASH24 https://t.co/iOEaZaNWbf
-
-
Mashup Score: 1Home - 7 day(s) ago
Activity Overview
Source: na.eventscloud.comCategories: General Medicine News, Oncologists1Tweet-
🔬 Discover the latest on complement-based therapies for PNH! Enhance your skills in identifying patients and creating tailored care plans. 🗣️ Boost your confidence in using effective communication for shared decision-making. Click here: https://t.co/VwFESDOQgO #ASH24 https://t.co/iOEaZaNWbf
-
-
Mashup Score: 1Home - 7 day(s) ago
Activity Overview
Source: na.eventscloud.comCategories: General Medicine News, Oncologists1Tweet-
🔬 Discover the latest on complement-based therapies for PNH! Enhance your skills in identifying patients and creating tailored care plans. 🗣️ Boost your confidence in using effective communication for shared decision-making. Click here: https://t.co/VwFESDOQgO #ASH24 https://t.co/iOEaZaNWbf
-
💓 @Prof_Nadia_H leads an exciting chat w/ @dradityabardia @Shaheenah1 @DrWGradishar about the future of ER-positive/HER2-negative MBC care, innovative treatments, resistance mechanisms, and patient-centered management. 𝐖𝐀𝐓𝐂𝐇 𝐋𝐈𝐕𝐄 𝐃𝐄𝐂 𝟏𝟗! https://t.co/xgyL84sUA8 https://t.co/qHuadPMwVs